Medical shop operating without licence raided, illegal stock seized

A medical shop in Alwal was raided by officials of the Telangana Drugs Control Administration (DCA) following a tip-off about illegal sale of medicines. During the inspection, officials discovered that the medical store was being operated illegally by the accused identified as Y.V. Subba Rao who did not have a valid drug licence.

During the raid, DCA teams uncovered medicines that were stocked without authorisation for commercial sale. The total value of the seized stock is estimated at ₹30,000.

According to officials, 20 different varieties of medicines, including anti-fungal drugs, painkillers, and medication used to treat erectile dysfunction were found on the premises. Samples of the seized medicines have been sent for laboratory analysis. The DCA has assured that appropriate legal action will be taken against all those found involved in the offence, said a release.

Related Posts

  • Pharma
  • July 10, 2025
  • 115 views
Pills & Profits: Can India’s pharma sector handle Trump’s planned 200% tariff dose?

India stands tall as a pharmaceutical powerhouse, supplying 20% of the world’s generic medicines and nearly 62% of global vaccines. Yet, this success now faces a storm: US President Donald…

  • Pharma
  • July 10, 2025
  • 98 views
Novartis wins approval for first malaria drug for newborns and babies

ZURICH: Novartis (NOVN.S), opens new tab said on Tuesday it had received approval in Switzerland for Coartem Baby, which it said was the first drug to treat malaria in babies…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Very Arty Surgery for Weight Loss by SSI Mantra, World’s First

Very Arty Surgery for Weight Loss by SSI Mantra, World’s First

Pills & Profits: Can India’s pharma sector handle Trump’s planned 200% tariff dose?

Pills & Profits: Can India’s pharma sector handle Trump’s planned 200% tariff dose?

Novartis wins approval for first malaria drug for newborns and babies

Novartis wins approval for first malaria drug for newborns and babies

Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr

Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr